MEK1/2 regulate normal BCR and ABL1 tumor-suppressor functions to dictate ATO response in TKI-resistant Ph+ leukemia.
- DOI
- 10.1038/s41375-023-01940-x
- Published
- 2023-06-29
- Container
- Leukemia
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41375-023-01940-x,
title = {MEK1/2 regulate normal BCR and ABL1 tumor-suppressor functions to dictate ATO response in TKI-resistant Ph+ leukemia.},
author = {Mazzera L and Abeltino M and Lombardi G and Cantoni AM and Jottini S and Corradi A and Ricca M and Rossetti E and Armando F and Peli A and Ferrari A and Martinelli G and Scupoli MT and Visco C and Bonifacio M and Ripamonti A and Gambacorti-Passerini C and Bonati A and Perris R and Lunghi P.},
year = {2023},
journal = {Leukemia},
doi = {10.1038/s41375-023-01940-x},
url = {https://doi.org/10.1038/s41375-023-01940-x}
}RIS
TY - JOUR TI - MEK1/2 regulate normal BCR and ABL1 tumor-suppressor functions to dictate ATO response in TKI-resistant Ph+ leukemia. AU - Mazzera L AU - Abeltino M AU - Lombardi G AU - Cantoni AM AU - Jottini S AU - Corradi A AU - Ricca M AU - Rossetti E AU - Armando F AU - Peli A AU - Ferrari A AU - Martinelli G AU - Scupoli MT AU - Visco C AU - Bonifacio M AU - Ripamonti A AU - Gambacorti-Passerini C AU - Bonati A AU - Perris R AU - Lunghi P. PY - 2023 JO - Leukemia DO - 10.1038/s41375-023-01940-x UR - https://doi.org/10.1038/s41375-023-01940-x ER -
APA
L, M., M, A., G, L., AM, C., S, J., A, C., M, R., E, R., F, A., A, P., A, F., G, M., MT, S., C, V., M, B., A, R., C, G., A, B., R, P., & P., L. (2023). MEK1/2 regulate normal BCR and ABL1 tumor-suppressor functions to dictate ATO response in TKI-resistant Ph+ leukemia.. Leukemia. https://doi.org/10.1038/s41375-023-01940-x
Source records
- europe-pmc · retrieved 2026-09-27T05:39:52.983Z